Global Lungs in Vitro Model Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Market Analysis by Type
  • 1.3.1 Global Lungs in Vitro Model Market Size Growth Rate by Type: 2020 VS 2026
  • 1.3.2 2D Cell Models
  • 1.3.3 3D Cell Models
• 1.4 Market by Application
  • 1.4.1 Global Lungs in Vitro Model Market Share by Application: 2020 VS 2026
  • 1.4.2 Drug Discovery and Toxicology
  • 1.4.3 3D Model Development
  • 1.4.4 Basic Research
  • 1.4.5 Physiological Research
  • 1.4.6 Stem Cell Research and Regenerative Medicine
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Lungs in Vitro Model Market Perspective (2015-2026)
• 2.2 Lungs in Vitro Model Growth Trends by Regions
  • 2.2.1 Lungs in Vitro Model Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Lungs in Vitro Model Historic Market Share by Regions (2015-2020)
  • 2.2.3 Lungs in Vitro Model Forecasted Market Size by Regions (2021-2026)
• 2.3 Lungs in Vitro Model Industry Dynamic
  • 2.3.1 Lungs in Vitro Model Market Trends
  • 2.3.2 Lungs in Vitro Model Market Drivers
  • 2.3.3 Lungs in Vitro Model Market Challenges
  • 2.3.4 Lungs in Vitro Model Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Lungs in Vitro Model Players by Market Size
  • 3.1.1 Global Top Lungs in Vitro Model Players by Revenue (2015-2020)
  • 3.1.2 Global Lungs in Vitro Model Revenue Market Share by Players (2015-2020)
• 3.2 Global Lungs in Vitro Model Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Lungs in Vitro Model Revenue
• 3.4 Global Lungs in Vitro Model Market Concentration Ratio
  • 3.4.1 Global Lungs in Vitro Model Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Lungs in Vitro Model Revenue in 2019
• 3.5 Key Players Lungs in Vitro Model Area Served
• 3.6 Key Players Lungs in Vitro Model Product Solution and Service
• 3.7 Date of Enter into Lungs in Vitro Model Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Lungs in Vitro Model Breakdown Data by Type

• 4.1 Global Lungs in Vitro Model Historic Market Size by Type (2015-2020)
• 4.2 Global Lungs in Vitro Model Forecasted Market Size by Type (2021-2026)

5 Lungs in Vitro Model Breakdown Data by Application

• 5.1 Global Lungs in Vitro Model Historic Market Size by Application (2015-2020)
• 5.2 Global Lungs in Vitro Model Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Lungs in Vitro Model Market Size (2015-2026)
• 6.2 North America Lungs in Vitro Model Market Size by Type (2015-2020)
• 6.3 North America Lungs in Vitro Model Market Size by Application (2015-2020)
• 6.4 North America Lungs in Vitro Model Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Lungs in Vitro Model Market Size (2015-2026)
• 7.2 Europe Lungs in Vitro Model Market Size by Type (2015-2020)
• 7.3 Europe Lungs in Vitro Model Market Size by Application (2015-2020)
• 7.4 Europe Lungs in Vitro Model Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Lungs in Vitro Model Market Size (2015-2026)
• 8.2 Asia-Pacific Lungs in Vitro Model Market Size by Type (2015-2020)
• 8.3 Asia-Pacific Lungs in Vitro Model Market Size by Application (2015-2020)
• 8.4 Asia-Pacific Lungs in Vitro Model Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia

9 Latin America

• 9.1 Latin America Lungs in Vitro Model Market Size (2015-2026)
• 9.2 Latin America Lungs in Vitro Model Market Size by Type (2015-2020)
• 9.3 Latin America Lungs in Vitro Model Market Size by Application (2015-2020)
• 9.4 Latin America Lungs in Vitro Model Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Lungs in Vitro Model Market Size (2015-2026)
• 10.2 Middle East & Africa Lungs in Vitro Model Market Size by Type (2015-2020)
• 10.3 Middle East & Africa Lungs in Vitro Model Market Size by Application (2015-2020)
• 10.4 Middle East & Africa Lungs in Vitro Model Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE

11Key Players Profiles

• 11.1 ATCC
  • 11.1.1 ATCC Company Details
  • 11.1.2 ATCC Business Overview
  • 11.1.3 ATCC Lungs in Vitro Model Introduction
  • 11.1.4 ATCC Revenue in Lungs in Vitro Model Business (2015-2020))
  • 11.1.5 ATCC Recent Development
• 11.2 Lonza
  • 11.2.1 Lonza Company Details
  • 11.2.2 Lonza Business Overview
  • 11.2.3 Lonza Lungs in Vitro Model Introduction
  • 11.2.4 Lonza Revenue in Lungs in Vitro Model Business (2015-2020)
  • 11.2.5 Lonza Recent Development
• 11.3 Epithelix
  • 11.3.1 Epithelix Company Details
  • 11.3.2 Epithelix Business Overview
  • 11.3.3 Epithelix Lungs in Vitro Model Introduction
  • 11.3.4 Epithelix Revenue in Lungs in Vitro Model Business (2015-2020)
  • 11.3.5 Epithelix Recent Development
• 11.4 Mattek
  • 11.4.1 Mattek Company Details
  • 11.4.2 Mattek Business Overview
  • 11.4.3 Mattek Lungs in Vitro Model Introduction
  • 11.4.4 Mattek Revenue in Lungs in Vitro Model Business (2015-2020)
  • 11.4.5 Mattek Recent Development
• 11.5 Emulate
  • 11.5.1 Emulate Company Details
  • 11.5.2 Emulate Business Overview
  • 11.5.3 Emulate Lungs in Vitro Model Introduction
  • 11.5.4 Emulate Revenue in Lungs in Vitro Model Business (2015-2020)
  • 11.5.5 Emulate Recent Development
• 11.6 Mimetas
  • 11.6.1 Mimetas Company Details
  • 11.6.2 Mimetas Business Overview
  • 11.6.3 Mimetas Lungs in Vitro Model Introduction
  • 11.6.4 Mimetas Revenue in Lungs in Vitro Model Business (2015-2020)
  • 11.6.5 Mimetas Recent Development
• 11.7 Tissuse
  • 11.7.1 Tissuse Company Details
  • 11.7.2 Tissuse Business Overview
  • 11.7.3 Tissuse Lungs in Vitro Model Introduction
  • 11.7.4 Tissuse Revenue in Lungs in Vitro Model Business (2015-2020)
  • 11.7.5 Tissuse Recent Development
• 11.8 Insphero
  • 11.8.1 Insphero Company Details
  • 11.8.2 Insphero Business Overview
  • 11.8.3 Insphero Lungs in Vitro Model Introduction
  • 11.8.4 Insphero Revenue in Lungs in Vitro Model Business (2015-2020)
  • 11.8.5 Insphero Recent Development
• 11.9 Cn Bio
  • 11.9.1 Cn Bio Company Details
  • 11.9.2 Cn Bio Business Overview
  • 11.9.3 Cn Bio Lungs in Vitro Model Introduction
  • 11.9.4 Cn Bio Revenue in Lungs in Vitro Model Business (2015-2020)
  • 11.9.5 Cn Bio Recent Development
• 11.10 AlveoliX
  • 11.10.1 AlveoliX Company Details
  • 11.10.2 AlveoliX Business Overview
  • 11.10.3 AlveoliX Lungs in Vitro Model Introduction
  • 11.10.4 AlveoliX Revenue in Lungs in Vitro Model Business (2015-2020)
  • 11.10.5 AlveoliX Recent Development
• 11.11 Oncotheis
  • 10.11.1 Oncotheis Company Details
  • 10.11.2 Oncotheis Business Overview
  • 10.11.3 Oncotheis Lungs in Vitro Model Introduction
  • 10.11.4 Oncotheis Revenue in Lungs in Vitro Model Business (2015-2020)
  • 10.11.5 Oncotheis Recent Development

12Analyst's Viewpoints/Conclusions

13Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer